Pathway Enrichment Analysis — Biological Pathway Enrichment Analysis
Biological Pathway Enrichment Analysis · Also known as: PEA, overrepresentation analysis, ORA, functional enrichment analysis
Pathway enrichment analysis (PEA) is a statistical approach that takes a list of genes or proteins of interest — typically derived from a differential expression or proteomics experiment — and identifies which pre-defined biological pathways or functional gene sets are represented more often than expected by chance. By mapping individual molecular changes onto curated pathway knowledge bases such as KEGG, Gene Ontology, or Reactome, PEA translates long gene lists into interpretable biological processes, making it a central tool in the post-analysis of high-throughput omics experiments.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
+43 more
When to use it
Use pathway enrichment analysis whenever a high-throughput omics experiment yields a gene or protein list that needs functional interpretation — including RNA-seq, proteomics, metabolomics (with HMDB/SMPDB databases), and GWAS locus annotations. ORA is appropriate when a clear significance threshold defines a discrete hit list; GSEA is preferable when the full ranked list should be used to detect subtle, coordinated pathway shifts. Do not use PEA as a primary analysis — it is always a post-processing step downstream of a quantitative experiment. Avoid it when the gene list is too short (fewer than ~20 genes), when it contains only a single highly pleiotropic hub gene, or when the biological question concerns individual gene function rather than pathway-level mechanisms. PEA is also unreliable when the pathway database lacks coverage for the organism or tissue type under study.
Strengths & limitations
- Converts large, hard-to-interpret gene lists into compact, biologically meaningful pathway summaries.
- Grounded in well-curated, community-maintained databases (GO, KEGG, Reactome) with broad organism coverage.
- Both ORA and GSEA variants are computationally fast and supported by mature, widely used R packages (clusterProfiler, fgsea, topGO).
- Applicable across multiple omics data types — transcriptomics, proteomics, metabolomics, and genomics — with appropriate databases.
- Results are directly actionable for hypothesis generation and experimental follow-up.
- Pathway databases are incomplete and biased toward well-studied genes; genes in underannotated pathways are systematically missed.
- ORA results depend heavily on the significance threshold used to define the input gene list — a different cutoff can substantially change enriched pathways.
- Pathways are not independent; genes shared across many pathways cause correlated test statistics and inflate apparent enrichment breadth.
- Standard methods treat all genes in a pathway as equally important and ignore network topology, expression magnitude, or interaction context.
Frequently asked
What is the difference between ORA and GSEA?
Overrepresentation analysis (ORA) requires a discrete gene list defined by a significance threshold and tests whether pathway genes appear more often in that list than expected under the hypergeometric distribution. GSEA uses the full ranked gene list (no cutoff) and tests whether pathway genes are concentrated toward the top or bottom of the ranking using a weighted Kolmogorov-Smirnov statistic. GSEA is more sensitive to subtle, coordinated pathway shifts; ORA is simpler and easier to explain but threshold-dependent.
Which pathway database should I use?
The choice depends on the biological question. Gene Ontology (GO) provides broad coverage of molecular functions, biological processes, and cellular components. KEGG emphasises metabolic and signalling pathways with well-curated diagrams. Reactome offers detailed, reaction-level pathway maps particularly strong for human signalling and metabolism. MSigDB (for GSEA) includes curated sets, motif-based sets, and empirical gene signatures. Using two or three complementary databases and looking for convergent results is good practice.
How do I handle redundant enrichment results?
Pathway databases have extensive gene overlap, so tens of similar pathways often appear significant simultaneously. Tools such as Revigo (for GO terms), clusterProfiler's enrichplot, or Cytoscape's EnrichmentMap can cluster, summarise, or visualise overlapping pathways. Reporting a representative pathway per cluster, rather than listing every overlapping term, produces clearer and more honest results.
Do I need to set a background gene list for ORA?
Yes, and this is a common source of error. The background must be all genes that were actually measured (expressed above detection threshold) in your experiment, not all genes in the genome. Using the full genome background inflates enrichment significance because many pathway genes are simply not detectable in any given tissue or condition.
Can pathway enrichment analysis establish causality?
No. PEA identifies statistical associations between a gene list and pathway annotations. It does not establish that those pathways are causally responsible for the observed phenotype. Enriched pathways are hypotheses that require experimental validation — for example, through perturbation experiments or mechanistic follow-up studies.
Sources
- Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. DOI: 10.1073/pnas.0506580102 ↗
- Alexa, A., Rahnenführer, J., & Lengauer, T. (2006). Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics, 22(13), 1600–1607. DOI: 10.1093/bioinformatics/btl140 ↗
How to cite this page
ScholarGate. (2026, June 3). Biological Pathway Enrichment Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/pathway-enrichment-analysis
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Gene Set Enrichment AnalysisBioinformatics↔ compare
- Metabolomics analysisBioinformatics↔ compare
- Network-based pathway enrichment analysisBioinformatics↔ compare
- Proteomics AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare
- Single-cell RNA-seq analysisBioinformatics↔ compare